Richard Henson is a seasoned business leader and entrepreneur with extensive expertise in the life sciences and medical technology industries. He graduated with a degree in EM from the Anderson School of Management at the University of California, Los Angeles, and has since held a variety of executive roles at companies such as ValVention, Inc., PhageTech, Inc., and Clary Corporation, among others.

As the CEO of NeorahDX, Inc., he leads the company's efforts to commercialize a recently developed, unique method of accurately self-testing for infections in less than an hour. This patented technology, based on NDX technology, allows for simple, self-administered tests using a nasal swab or saliva sample. Unlike current testing methods, no laboratory or instruments are required, and results are delivered via a visual color change, similar to a pregnancy test. This technology has the potential to meet the urgent needs of hundreds of millions of people at risk for the virus and disrupt current testing methods significantly.

Richard is well-known in the industry and has served in various leadership roles, including co-founder and CEO of Source Scientific, LLC, chairman of the board of the LINC - Life Science Industry Council, and managing director of GUTOR USA Division at American Power Conversion (Switzerland), to name a few. He is well-versed in scaling up companies and securing funding, having navigated multiple grant programs and secured non-dilutive and equity capital for NeorahDX, Inc.

Richard's background and experience make him a valuable asset to any team in the life sciences and medical technology industries.